Skip to main content
Fig. 2 | Lipids in Health and Disease

Fig. 2

From: The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia

Fig. 2

TG reduction observed with varying doses of omega-3 carboxylic acids, omega-3 ethyl esters, and icosapent ethyl in (a) patients with severe hypertriglyceridemia (TG ≥ 500 mg/dL) [14, 16, 17] and (b) statin-treated patients with high baseline TG levels (TG level ≥ 200 mg/dL and < 500 mg/dL) [20, 21, 24] Data not available for OM3EE at 2 g/day. OM3CA = Percentage change from baseline expressed as least-squares geometric mean; OM3EE = percentage change from baseline expressed as geometric mean; IPE = percentage change from baseline expressed as median. Placebo used = olive oil; Placebo used = vegetable oil; §Placebo used = mineral oil; ǁPlacebo used = corn oil; Placebo not specified. IPE icosapent ethyl, OM3CA omega-3 carboxylic acids, OM3EE omega-3 ethyl esters, TG triglyceride

Back to article page